** Shares of drugmaker Fennec Pharmaceuticals FENC.O rise 3.3% to $6.47
** Company reports Q1 sales rose 18% to $8.8 million, compared with analysts' estimates of $8.2 million - data compiled by LSEG
** Company posts quarterly net loss of 4 cents per share vs estimated loss of 9 cents per share
** As of last close, stock down 0.8% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.